| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -175,179 | -125,672 |
| Goodwill impairments | 71,763 | 59,138 |
| Amortization of intangible assets | 258,725 | 172,968 |
| Depreciation of property and equipment | 10,514 | 7,902 |
| Amortization of right-of-use assets | 7,973 | 4,190 |
| Provision for allowances for doubtful accounts | -481 | 377 |
| Stock-based compensation | 64,503 | 47,507 |
| Deferred income taxes | -31,449 | -34,072 |
| Other, net | -3,272 | -2,049 |
| Accounts receivable | -7,664 | 8,497 |
| Prepaid expenses and other current assets | 1,326 | 16,434 |
| Inventory | 1,039 | -861 |
| Other assets | -6,391 | -7,616 |
| Accounts payable | 16,256 | 19,278 |
| Accrued expenses and other current liabilities | -2,247 | -5,149 |
| Accrued compensation | -4,795 | -9,545 |
| Deferred revenue | -9,777 | -6,084 |
| Operating lease liabilities | -10,249 | -5,170 |
| Other liabilities | -3,904 | -3,912 |
| Net cash provided by operating activities | 206,615 | 107,351 |
| Capital expenditures | 6,274 | 3,994 |
| Capitalized software development costs | 86,862 | 57,824 |
| Proceeds from the sale of investment | 740 | 740 |
| Acquisitions accounted for as business combinations, net of cash acquired | 81,904 | 65,302 |
| Asset acquisition resulting in net intangible assets | 29,569 | 29,569 |
| Payments for investments | 27,875 | 27,075 |
| Other, net | -60 | -60 |
| Net cash used in investing activities | -231,684 | -182,964 |
| Proceeds from the exercise of stock options | 81 | 81 |
| Proceeds from employee stock purchase plan | 1,901 | 1,384 |
| Repayment of convertible senior notes | 550,629 | 550,629 |
| Payment of credit facility issuance costs | 4,109 | - |
| Other, net | 0 | 0 |
| Net cash (used in) provided by financing activities | -552,756 | -549,164 |
| Net (decrease) increase in cash and cash equivalents | -577,825 | -624,777 |
| Effect of exchange rate changes on cash | 5,747 | - |
| Cash and cash equivalents at beginning of period | 1,298,327 | - |
| Cash and cash equivalents at end of period | 726,249 | - |
Teladoc Health, Inc. (TDOC)
Teladoc Health, Inc. (TDOC)